Fibronectin type III domain based scaffold compositions, methods and uses
A protein scaffold based on a consensus sequence of fibronectin type III (FN3) proteins, such as the tenth FN3 repeat from human fibronectin (human Tenascin), including isolated nucleic acids that encode a protein scaffold, vectors, host cells, and methods of making and using thereof have applications in diagnostic and/or therapeutic compositions, methods and devices. In particular, protein scaffold molecules binding to IgG have been identified as useful for diagnostic and/or therapeutic applications.
1. A library produced by a method of constructing a library of a protein scaffold based on a fibronectin type III (FN3) domain derived from a consensus sequence of an FN3 domain, comprising the steps of:
providing a polypeptide derived from a consensus sequence of an FN3 domain having at least 90% identity to the amino acid sequence of SEQ ID NO:16; and
introducing diversity into copies of the polypeptide to form the protein scaffold library.
2. A method of generating a protein scaffold binding to a specific target protein or nucleotide with a predefined binding affinity, comprising contacting the library of claim 1 with the specific target protein or nucleotide and isolating a protein scaffold binding to the specific target protein or nucleotide with the predefined affinity.
3. The method of claim 2 , wherein the isolating step comprises isolating scaffold molecules binding to the specific target protein or nucleotide and testing the isolated scaffold molecules for binding affinity to the specific target protein or nucleotide.
4. The method of claim 3 , wherein the isolating step comprises panning the library with the specific target protein or nucleotide, identifying scaffold molecules binding to the specific target protein or nucleotide, and isolating the binding scaffold molecules.
5. The method of claim 3 , wherein the affinity is less than or equal to about 10 −7 M.
6. A library produced by a method of constructing a library of a protein scaffold based on a fibronectin type III (FN3) domain, comprising the steps of:
providing a polypeptide having the amino acid sequence of SEQ ID NO:16; and
introducing diversity into copies of the polypeptide having the amino acid sequence of SEQ ID NO:16 to form the protein scaffold library, wherein the introducing diversity step comprises mutating at least one loop region selected from the group consisting of residues at or about positions 13-16, 22-28, 38-43, 51-54, 60-64, and 75-81 of SEQ ID NO:16.
7. A method of generating a protein scaffold binding to a specific target with a predefined binding affinity, comprising contacting the library of claim 6 with the specific target protein or nucleotide and isolating a protein scaffold binding to the specific target protein or nucleotide with the predefined affinity.
8. The method of claim 7 , wherein the isolating step comprises isolating scaffold molecules binding to the specific target protein or nucleotide and testing the isolated scaffold molecules for binding affinity to the specific target protein or nucleotide.
9. The method of claim 8 , wherein the isolating step comprises panning the library with the specific target protein or nucleotide, identifying scaffold molecules binding to the specific target protein or nucleotide, and isolating the binding scaffold molecules.
10. The method of claim 8 , wherein the affinity is less than or equal to about 10 −7 M.
11. A medical device, comprising an isolated protein scaffold comprising a fibronectin type III (FN3) domain having at least 90% identity to the amino acid sequence of SEQ ID NO:16, wherein said device is suitable for contacting or administering said protein scaffold by at least one mode selected from parenteral, subcutaneous, intramuscular, intravenous, intrarticular, intrabronchial, intraabdominal, intracapsular, intracartilaginous, intracavitary, intracelial, intracerebellar, intracerebroventricular, intracolic, intracervical, intragastric, intrahepatic, intramyocardial, intraosteal, intrapelvic, intrapericardiac, intraperitoneal, intrapleural, intraprostatic, intrapulmonary, intrarectal, intrarenal, intraretinal, intraspinal, intrasynovial, intrathoracic, intrauterine, intravesical, intralesional, bolus, vaginal, rectal, buccal, sublingual, intranasal, and transdermal.